Palabras clave
dapsone
hidradenitis suppurativa
rosacea
Cómo citar
Resumen
Dapsone is a chemical compound belonging to the sulfone group, primarily used as a first-line treatment for leprosy. Beyond this indication, it possesses a broad spectrum of antibacterial, antiparasitic, immunosuppressive/immunomodulatory, and anti-inflammatory properties, playing a key role in the management of numerous dermatological conditions. It is considered the first-line therapy for dermatitis herpetiformis and erythema elevatum diutinum. Additionally, it is employed in the treatment of other skin disorders such as bullous pemphigoid, mucous membrane pemphigoid, cutaneous lupus erythematosus, among others. This article discusses the therapeutic potential of dapsone in the treatment of acne vulgaris, rosacea, and hidradenitis suppurativa. Furthermore, an overview of dosing regimens used in other dermatological diseases is provided.
Referencias
Żychowska M., Batycka-Baran A., Szepietowski J. et al.: Dapsone – mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations. Dermatol Rev 2016; 103(2): 176-184.
Yoshimura T., Matsushima K., Tanaka S. et al.: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987; 84(24): 9233-9237.
Rabindranathnambi A., Jeevankumar B.: Dapsone in Hidra- denitis Suppurativa: A Systematic Review. Dermatol Ther (Heidelb) 2022; 12(2): 285-293.
Maymone M.B.C., Venkatesh S., Laughter M. et al.: Leprosy: Treatment and management of complications. J Am Acad Dermatol 2020; 83(1): 17-30.
Ghaoui N., Hanna E., Abbas O. et al.: Update on the use of dapsone in dermatology. Int J Dermatol 2020; 59(7): 787-795.
Bieber T.: Dapson und Clofazimine: Wie und wozu?. In: Plewig G., Prinz J., eds. Fortschritte der praktischen Dermatologie und Venerologie. Berlin, Heidelberg: Springer; 2003. 200-204.
Duan L., Chen L., Zhong S. et al.: Treatment of Bullous Systemic Lupus Erythematosus. J Immunol Res 2015; 2015: 167064.
Hrin M.L., Feldman S.R., Huang W.W.: Dapsone as corticosteroid-sparing therapy for Sweet syndrome. J Am Acad Dermatol 2022; 86(3): 677-679.
Głuszak P., Beutler J., Kurkowska N. et al. Dapson in the Treatment of Pyoderma Gangrenosum: a Narrative Review. Dermatol Rev 2024; 111(5): 347-357.
Temiz S.A., Daye M.: Dapsone for the treatment of acne vulgaris: do the risks outweigh the benefits? Cutan Ocul Toxicol 2022; 41(1): 60-66.
Moore A.Y., Lain E.L., McMichael A. et al.: Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Pre- adolescent Patients: A Phase IV, Open-label, 12-week Study. J Clin Aesthet Dermatol 2021; 14(4): 43-48.
Hasanbeyzade S., Şenel E.: Comparison of topical dapsone + tretinoin and clindamycin + tretinoin combination in terms of effectiveness in the treatment of mild and moderate acne vulgaris: a retrospective analysis. Arch Dermatol Res 2025; 317(1): 272.
Gharib K., Samir M., Mohamed G. et al.: Efficacy and safety of topical spironolactone versus topical dapsone in the treatment of acne vulgaris. Arch Dermatol Res 2024; 316(10): 732.
Legal K., Misery L.: Isotretinoin-induced Acne Fulminans without Systemic Symptoms Treated Successfully with Oral Dapsone. Acta Derm Venereol 2020; 100(1): adv00036.
Gökşin Ş., İmren I.G., Kaçar N.: Efficacy of Topical Dapsone 5% Gel for the Treatment of Erythematotelangiectatic Rosacea: New Treatment Option with Old Drug. Dermatol Pract Concept 2024; 14(1): e2024034.
Özkoca D., Caf N.: The treatment efficacy of 7.5% dapsone gel in papulopustular rosacea: a prospective study. Cutaneous Ocul Toxicol 2024; 43(4): 405-409.
Merlo G., Cozzani E., Russo R. et al.: Dapsone for Unresponsive Granulomatous Rosacea. Am J Ther 2020; 27(3): e304-306.
Bormann G., Gaber G., Fischer M. et al.: Dapsone in rosacea fulminans. J Eur Acad Dermatol Venereol 2001; 15(5): 465-467.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Derechos de autor 2025 Review of Medical Practice